Q: Are disposable instrumentation tools, those typically used in endoscopic or cardiac procedures, considered integral to the procedure or are they separately chargeable?
CMS announced blanket waivers of certain Medicare requirements to prevent gaps in care for beneficiaries affected by the novel coronavirus (COVID-19) public health emergency. The agency released billing instructions and a set of Q&As.
To enhance efforts to combat the opioid crisis in America, CMS policy allows for a new benefit under Medicare Part B concerning Opioid Treatment Programs.
The American Medical Association (AMA) announced Friday that its CPT® Editorial Panel expedited approval of a unique CPT code to report laboratory testing services for COVID-19. The new code supports the urgent public health need for streamlined reporting of testing for the novel coronavirus.
CMS provided updated coding and billing information in its Clinical Laboratory Fee Schedule (CLFS) for organizations performing tests for COVID-19 and providing treatment for confirmed or suspected COVID-19 infections.
The Centers for Disease Control and Prevention (CDC) is monitoring the rapid spread of a novel 2019 coronavirus, formally named COVID-19, first identified in Wuhan, Hubei Province, China. On January 30, the International Health Regulations Emergency Committee of the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern due to its sustained person-to-person spread within countries and across continental borders.
Findings from an Office of Inspector General (OIG) audit show that CHI St. Vincent Infirmary, a regional health network in Arkansas, improperly billed for 103 of 120 sampled claims related to outlier payments, which resulted in the improper billing of outliers totaling $581,136.
Navigating Medicare’s rules for charging for ancillary services, bedside procedures, and supplies is no easy task. Get an expert perspective on how to apply the rules.
